USPTO serial 79458819
Reviewed by CopyMark Law Group
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for cosmetic surgery, reconstructive surgery or dermatological purposes; pharmaceutical preparations containing botulinum toxin; pharmaceuticals containing botulinum toxin; pharmaceutical preparations for preventing and treating obesity; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; filled syringes for medical purposes [containing pharmaceuticals]; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; cellular function activating agents for medical purposes; drugs for medical purposes; sodium hyaluronate gels for medical purposes; pharmaceutical drugs; pharmaceuticals; medicines for human purposes; implants for guided tissue regeneration; tissue-regenerative pharmaceutical preparations; injectable preparations for wrinkle reduction; injectable dermal fillers; stem cells; pharmaceutical preparations for dermal regeneration; medical preparations for slimming purposes; slimming pills; injectable preparations for therapeutic facial contouring; pharmaceutical preparations for skin regeneration containing polydeoxyribonucleotide (PDRN); injectable pharmaceutical preparations containing polydeoxyribonucleotide (PDRN); skin hydrators being injectable dermal fillers; injectable pharmaceutical preparations for reducing skin wrinkles; gels, creams and solutions for dermatological use; injectable pharmaceutical preparations for skin hydration and wrinkle reduction; medicated preparations for skin treatment. | ACTIVE | — |
| 010 | Esthetic massage apparatus for household use; high frequency warmer therapeutic appliances; high-frequency skin esthetic massage apparatus (not for medical purposes); light therapy apparatus; medical skin enhancement apparatus using lasers; electric scalp measuring instruments for physical therapy purposes; electric skin measuring devices for use as parts of esthetic massage apparatus; medical apparatus for non-surgical cosmetic treatment; surgical implants for cosmetic procedures namely wrinkle removal; drug syringes; medical instruments; high-frequency stimulators for medical purposes; high-frequency skin care equipment for medical purpose; medical cryolipolysis apparatus; low frequency skin esthetic apparatus for medical purposes; wrinkle removal apparatus for medical purposes; medical syringe needles; medical injection syringe; esthetic massage apparatus using ultrasonic waves; ultrasonic medical diagnostic apparatus; medical ultrasonic apparatus for skin treatment; medical esthetic machine for skin massage; medical apparatus for injecting fillers; apparatus for electrical muscle stimulation; electric esthetic massage apparatus; electric facial aesthetic treatment apparatus, other than facial steamers; medical skin esthetic apparatus with electrical stimulation; ultrasonic therapy machines and apparatus; dermatological laser handpiece; esthetic facial massage apparatus for skin whitening effect; medical apparatus for skin wrinkle removal; lasers for skin treatment. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |